Cancer Drugs Approved Quickly Often Fail To Measure Up Later
Regulators give many cancer drugs a fast track to market while requiring drugmakers to do more studies after approval. Researchers have found the follow-up studies frequently come up short.
Read more on NPR
May 29, 2019 at 12:56AM
Health Care
Thứ Tư, 29 tháng 5, 2019
Đăng ký:
Đăng Nhận xét (Atom)
0 nhận xét:
Đăng nhận xét